Concepedia

Mary R. Giancarli

MR

Statistics

Publications

11

Citations

558

H-Index

10

Active since

1992

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Bristol-Myers Squibb (Sweden)

Mary R. Giancarli is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, medicine, and endothelin receptor antagonists.

Publications per year

1992–2017

11

Publications

11

Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleeding

Pancras C. Wong, Dietmar Seiffert, J. Eileen Bird et al. · Science Translational Medicine · 2017 · 149 citations

, , +14

Cardiovascular effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme BMS-182657 in experimental hypertension and heart failure.

N. C. Trippodo, Jeffrey A. Robl, Magdi M. Asaad et al. · Journal of Pharmacology and Experimental Therapeutics · 1995 · 84 citations

, , +17

Increased severity of glomerulonephritis in C-C chemokine receptor 2 knockout mice

J. Eileen Bird, Mary R. Giancarli, Takao Kurihara et al. · Kidney International · 2000 · 67 citations · Full text

, , +14

Novel Dual Action AT1 and ETA Receptor Antagonists Reduce Blood Pressure in Experimental Hypertension

Mark C. Kowala, Natesan Murugesan, John E. Tellew et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 52 citations

, , +17

Captopril prevents nephropathy in HIV-transgenic mice.

J. Eileen Bird, Stephen K. Durham, Mary R. Giancarli et al. · Journal of the American Society of Nephrology · 1998 · 43 citations

, , +16

1–5 of 11